Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy
Advanced Science · 2024
DOI: 10.1002/advs.202310002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Haochen Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary and Pancreatic Surgery Department, General Surgery Center, First Hospital of Jilin University, No.1 Xinmin Street, Changchun, Jilin, 13…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Gastrointestinal Microbiome, Liver Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jilin Province Science and Technology Department Plan, National Key Research and Development Program of China.
Abstract (Originalsprache)
Reversing the hepatic inflammatory and immunosuppressive microenvironment caused by gut microbiota‐derived lipopolysaccharides (LPS), accumulating to the liver through the gut‐liver axis, is crucial for suppressing hepatocellular carcinoma (HCC) and metastasis. However, synergistically manipulating LPS‐induced inflammation and gut microbiota remains a daunting task. Herein, a Trojan‐horse strategy is proposed using an oral dextran‐carbenoxolone (DEX‐CBX) conjugate, which combines prebiotic and glycyrrhetinic acid (GA) homologs, to targeted delivery GA to HCC through the gut‐liver axis for simultaneous modulation of hepatic inflammation and gut microbiota. In the orthotopic HCC model, a 95–45% reduction in the relative abundances of LPS‐associated microbiota is observed, especially Helicobacter , caused by DEX‐CBX treatment over phosphate‐buffered saline (PBS) treatment. Notably, a dramatic increase (37‐fold over PBS) in the abundance of Akkermansia , which is known to strengthen systemic immune response, is detected. Furthermore, DEX‐CBX significantly increased natural killer T cells (5.7‐fold) and CD8 + T cells (3.9‐fold) as well as decreased M2 macrophages (59% reduction) over PBS treatment, resulting in a tumor suppression rate of 85.4%. DEX‐CBX is anticipated to offer a novel strategy to precisely modulate hepatic inflammation and the gut microbiota to address both the symptoms and root causes of LPS‐induced immunosuppression in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary and Pancreatic Surgery Department, General Surgery Center, First Hospital of Jilin University, No.1 Xinmin Street, Changchun, Jilin, 130021, China.
- Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, 130021, China.
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Road, Changchun, 130022, China.
- Jilin Biomedical Polymers Engineering Laboratory, Changchun Institute of Applied Chemistry, 5625 Renmin Road, Changchun, 130022, China.
- Department of Computational Mathematics, School of Mathematics, Jilin University, Changchun, 130012, China.
- Department of Molecular Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, China.
ORCID-Profile: Haochen Yao, Guoqing Wang
Förderung
- National Natural Science Foundation of China
- Jilin Province Science and Technology Department Plan
- National Key Research and Development Program of China
- National Postdoctoral Program for Innovative Talents
- the Youth Talents Promotion Project of Jilin Province
- First Hospital of Jilin University
- Jilin University Norman Bethune Research Program
- Basic Research Projects of Jilin University
Zitieren
APA
Yao, H., Ma, S., Huang, J., Si, X., Yang, M., Song, W., Lv, G., & Wang, G. (2024). Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science. https://doi.org/10.1002/advs.202310002
Vancouver
Yao H, Ma S, Huang J, Si X, Yang M, Song W, et al. Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science. 2024. doi:10.1002/advs.202310002
BibTeX
@article{Yao2024,
author = {Yao, Haochen and Ma, Sheng and Huang, Juanjuan and Si, Xinghui and Yang, Ming and Song, Wantong and Lv, Guoyue and Wang, Guoqing},
title = {Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202310002}
}
EUVIMED